John Buckley Eagan - 01 Aug 2026 Form 3 Insider Report for Beacon Financial Corp (BBT)

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
3
Accepted by SEC
04 Aug 2026, 11:34:38 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
John Buckley Eagan by Marissa Martin, POA

Key filing fact

John Buckley Eagan filed Form 3 for Beacon Financial Corp (BBT) on 04 Aug 2026.

Key facts

  • This page summarizes John Buckley Eagan's Form 3 filing for Beacon Financial Corp (BBT).
  • 0 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 04 Aug 2026, 11:34.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002146758 Primary reporting owner

Eagan John Buckley

Relationship
General Counsel
Address
131 CLARENDON STREET, BOSTON
Signature
John Buckley Eagan by Marissa Martin, POA
Signature date
04 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BBT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
7,961
Date
01 Aug 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Includes shares of restricted stock granted pursuant to the 2025 Beacon Financial Corporation Stock Option and Incentive Plan.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .